ImmunityBio, Inc. IBRX
Set alert
8.22 USD +0.27 +3.40%
As of Nov 3, 12:34 PM ET
7.97 Day range 8.43
1.95 52-week range 12.43
- YTD
- +315.15%
- 1 year
- +263.72%
- Open
- 8.00
- Prev close
- 7.95
- Mkt cap
- 8.72B
- Vol
- 2.90M
- Avg vol
- 11.49M
- EPS
- -0.96
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 7.97
- High
- 8.43
- Forward P/E
- -108.41
- Beta
- 0.17
- Short ratio
- 7.96
- Inst. own
- 19.81%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 8.71
- 200-d avg
- 7.90
- 1y target
- 14.25
1M chart
Events in this range
- Oct 15, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Oct 15, 2026Rating: Jefferies · Buy → Buy
- Nov 3, 2026Earnings: —; estimate -0.07; surprise —%
Signals (9)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 28, 2026 | 6 days ago |
| SMA: Bullish | Oct 28, 2026 | 6 days ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 19, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 3 weeks ago |
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 14.25 +73.4% upside
Now 8.22
- Target (low)
- 12.00
- Target (mean)
- 14.25
- Target (high)
- 16.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy1
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.05 | -0.09 – 0.00 | -0.07 | +28.6% | 59.23M | +84.7% | 3 |
| Next quarter | -0.04333 | -0.09 – 0.00 | -0.06 | +27.8% | 72.04M | +88.2% | 3 |
| Current year | -0.915 | -0.93 – -0.90 | -0.38 | -140.8% | 226.56M | +100.0% | 2 |
| Next year | -0.07333 | -0.32 – 0.10 | -0.915 | +92.0% | 471.90M | +108.3% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 15, 2026 | Jefferies | Maintained | Buy | Buy |
| Oct 15, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 2, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 21, 2026 | BTIG | Reiterated | Buy | Buy |
| May 20, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 5, 2026 | D. Boral Capital | Maintained | Buy | Buy |
| Apr 21, 2026 | D. Boral Capital | Maintained | Buy | Buy |
| Apr 8, 2026 | D. Boral Capital | Maintained | Buy | Buy |
| Mar 26, 2026 | D. Boral Capital | Maintained | Buy | Buy |
| Mar 23, 2026 | D. Boral Capital | Maintained | Buy | Buy |
| Mar 17, 2026 | D. Boral Capital | Maintained | Buy | Buy |
| Mar 9, 2026 | D. Boral Capital | Maintained | Buy | Buy |
| Mar 4, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Feb 23, 2026 | D. Boral Capital | Maintained | Buy | Buy |
| Feb 23, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 19, 2026 | D. Boral Capital | Maintained | Buy | Buy |
| Feb 17, 2026 | D. Boral Capital | Maintained | Buy | Buy |
| Jan 26, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jan 23, 2026 | D. Boral Capital | Maintained | Buy | Buy |
| Jan 23, 2026 | BTIG | Maintained | Buy | Buy |
| Jan 20, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jan 20, 2026 | D. Boral Capital | Maintained | Buy | Buy |
| Jan 16, 2026 | D. Boral Capital | Maintained | Buy | Buy |
| Jan 13, 2026 | D. Boral Capital | Maintained | Buy | Buy |
| Dec 16, 2025 | D. Boral Capital | Maintained | Buy | Buy |
| Dec 12, 2025 | Jefferies | Maintained | Buy | Buy |
| Dec 12, 2025 | D. Boral Capital | Maintained | Buy | Buy |
| Dec 11, 2025 | D. Boral Capital | Maintained | Buy | Buy |
| Nov 13, 2025 | D. Boral Capital | Maintained | Buy | Buy |
| Nov 5, 2025 | D. Boral Capital | Maintained | Buy | Buy |